-- Astellas, Elpida, Komatsu, Sony, Toyota Motor: Japanese Stocks
-- B y   M a s a a k i   I w a m o t o
-- 2012-01-24T06:40:08Z
-- http://www.bloomberg.com/news/2012-01-24/komatsu-terumo-toyota-yaskawa-yurtec-japanese-stocks.html
Japan ’s  Nikkei 225 (NKY)  Stock Average
rose 19.43, or 0.2 percent, to 8785.33 at the 3 p.m. close in
 Tokyo . The following are among the most active shares in the
Japanese  market  today. Stock symbols are in parentheses after
company names.  Astellas Pharma Inc. (4503)  (4503 JT), gained 3.2 percent to 3,110
yen. Jefferies & Co Inc. said Astellas remains the top pick in
the Japanese pharmaceutical sector for 2012, citing the possible
approval for multiple drugs this year and limited risk for
patent expiry or erosion by generics for mainstay products.  Daiei Inc. (8263)  (8263 JT), a supermarket chain, rose 1.1 percent
to 278 yen. The company targets paying its first dividend in 16
years, President Michio Kuwahara said in an interview.  Elpida Memory Inc. (6665)  (6665 JT), a chipmaker, rose 4.6 percent
to 367 yen. The company is in final talks with Micron Technology
Inc. and Nanya Technology Corp. for a three-way merger, the
Yomiuri newspaper reported, without saying where it got the
information.  Inpex Corp. (1605)  (1605 JT), an oil and natural gas explorer,
advanced 2.2 percent to 517,000 yen. Crude oil futures on the
NYMEX rose 1.1 percent yesterday after the European Union agreed
to ban crude imports from  Iran , raising concern about supply
disruptions from the  Middle East .  Komatsu Ltd. (6301)  (6301 JT), Japan’s largest construction
machinery maker, gained 1 percent to 2,113 yen. The company
canceled 15.6 million of its shares, or 1.6 percent of the total,
according to a statement to the Tokyo Stock Exchange.  Nippon Steel Corp. (5401)  (5401 JT) lost 3 percent to 197 yen. J.P
Morgan Securities lowered its price target to 240 from 250 yen,
saying earnings will probably be pressured by deteriorating
profits on exports and domestic general-purpose products.  Seiko Epson Corp. (6724)  (6724 JT), an electric device maker, fell
1.5 percent to 975 yen. Daiwa Securities Capital Markets cut its
investment rating to “neutral” from “outperform,” saying
full-year operating profit will miss the company’s forecast.  Sony Corp. (6758 JT) fell 2.4 percent to 1,388 yen. The
company offered to take as much as a 30 percent stake in  Olympus
Corp. (7733)  (7733 JT) as part of a business alliance proposal, the
Nikkei newspaper reported, without citing anyone.  Suzuki Motor Corp. (7269)  (7269 JT) rose 2.4 percent to 1,685 yen.
The chief financial officer of Maruti Suzuki India Ltd., a
subsidiary of Suzuki, said the worst is over and new cars and
increased supply of  diesel engines  would help boost sales next
year. Maruti Suzuki reported a 64 percent drop in net income for
the three months ended December compared with a year earlier.  Takeda Pharmaceutical Co. (4502 JT),  Asia ’s biggest drug
maker, advanced 1.7 percent to 3,300 yen. The company won U.S.
approval to administer its cancer medicine Velcade under the
skin, a form of injection that causes fewer patients to
experience the drug’s side effects, according to a statement.  Tokyo Steel Manufacturing Co. (5423 JT), an electric
furnace steelmaker, jumped 4.2 percent to 596 yen. The company
maintained its steel material prices in February, according to
the company’s website.  Toyota Motor Corp. (7203)  (7203 JT) gained 2.7 percent to 2,793
yen. The Australian subsidiary of Asia’s largest carmaker will
cut 350 jobs at its manufacturing plant in Victoria after
production fell 21 percent in 2011.  Yurtec Corp. (1934)  (1934 JT), a construction company, rose 3.3
percent to 413 yen. The company raised its full-year net-income
forecast 18 percent to 2 billion yen. The unit of Tohoku
Electric Power Co. (8506 JT) cited the rise in revenue due to
post-quake projects for the improved outlook.  To contact the reporter on this story:
Masaaki Iwamoto in Tokyo at 
 miwamoto4@bloomberg.net   To contact the editor responsible for this story:
Nick Gentle at 
 ngentle2@bloomberg.net  